This compound is primarily utilized in research settings to study glycosphingolipid metabolism. It acts as an inhibitor of glucosylceramide synthase, an enzyme involved in the biosynthesis of glycosphingolipids. By inhibiting this enzyme, it helps researchers understand the role of glycosphingolipids in various cellular processes, including cell signaling and membrane structure. Additionally, it is used in studies related to diseases where glycosphingolipid accumulation is a factor, such as Gaucher disease and other lysosomal storage disorders. Its application extends to exploring potential therapeutic strategies for these conditions by modulating glycosphingolipid levels.